ABX advanced biochemical compounds GmbH
Martin Kaiser has extensive experience in IT system integration, primarily within the biotechnology sector. Currently serving as a Fachinformatiker Systemintegration at ABX advanced biochemical compounds GmbH since April 2018, Martin previously held similar positions at CNS from July 2014 to March 2018 and at ABX advanced biochemical compounds GmbH from August 2012 to July 2014. Martin's educational background includes an IHK Abschluss in Fachinformatiker with a specialization in Systemintegration, obtained from Donner + Partner GmbH between 2010 and 2012.
This person is not in the org chart
This person is not in any teams
ABX advanced biochemical compounds GmbH
ABX advanced biochemical compounds is a global frontrunner in radiopharmaceuticals, with a focus on positron emission tomography (PET) tracers. We develop and produce all compounds and components for any kind of radiotracer – from PET and SPECT precursors, PET reagent kits and cassettes, to complete radiopharmaceutical drug production in GMP environment. Based in Radeberg, Germany, and founded in 1997, our team of more than 350 employees is specialised in custom synthesis and manufacturing of precursors and peptides according to GMP for active pharmaceutical ingredients. Thanks to our expertise combined with bleeding edge equipment, we reach highest research, production, and quality standards. For example, we operate a hot lab for R&D of new radiopharmaceutical kits and cassettes for our own product portfolio and in cooperation with pharmaceutical companies. Our extensive laboratory space enables us to perform stability studies of our products and in-house sterility testing of radioactive pharmaceuticals. Thanks to our production of aseptic excipients and sterile disposables, we are largely independent from external sourcing. We are also authorized producer of radiopharmaceutical drugs. Furthermore, we are experts in ASMFs, US-DMFs and technical documents for reagent kits, cassettes, PET and SPECT precursors.